January 28, 2020

Ascend Capital Founder Malcolm Fairbairn Appointed to TFF Pharmaceuticals Board of Directors

January 28, 2020

TFF Pharmaceuticals Reports Continued Progress Across Programs in Corporate Update

January 7, 2020

TFF Pharmaceuticals’ Scientific Consultant Robert O. Williams III Named to National Academy of Inventors

December 11, 2019

TFF Pharmaceuticals to Meet with Investors and Commercial Partners in San Francisco during the JP Morgan Healthcare Conference

December 9, 2019

TFF Pharmaceuticals Reports Third Quarter Results and Provides Business Update

November 25, 2019

TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)

November 19, 2019

TFF Pharmaceuticals Selects LaVoieHealthScience as Investor Relations and Corporate Communications Partner

November 18, 2019

TFF Pharmaceuticals to Ring NASDAQ Stock Market Opening Bell on Wednesday, November 20, 2019

October 24, 2019

TFF Pharmaceuticals Prices $22 Million Public Offering of Common Stock

May 30, 2019

TFF Pharmaceuticals Raises $8.17 Million and Expands Leadership Team with New CFO and Director Appointments